Diagnostic and prognostic value of serum soluble suppression of tumorigenicity-2 in heart failure with preserved ejection fraction: A systematic review and meta-analysis

BACKGROUND: Heart failure (HF) with preserved ejection fraction (HFpEF) is a growing public health burden, with mortality and rehospitalization rates comparable to HF with reduced ejection fraction (HFrEF). The evidence for the clinical usefulness of soluble suppression of tumorigenicity 2 (sST2) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yujiao, Liu, Jiangang, Liu, Chunqiu, Shuang, Xiong, Yang, Chenguang, Qiao, Wenbo, Dong, Guoju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530661/
https://www.ncbi.nlm.nih.gov/pubmed/36204571
http://dx.doi.org/10.3389/fcvm.2022.937291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530661/
https://www.ncbi.nlm.nih.gov/pubmed/36204571
http://dx.doi.org/10.3389/fcvm.2022.937291

Ejemplares similares